secwatch.observer — SEC 8-K summary
======================================

Issuer:     Gain Therapeutics, Inc. (GANX)
CIK:        0001819411
Form:       8-K
Filed at:   2026-06-25T21:00:40+00:00
Accession:  0001104659-26-077820
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Gain Therapeutics elects seven directors, ratifies auditor at annual meeting
----------------------------------------------------------------------------

- All seven director nominees elected: Mack, Goldstein, Hasler, Islam, Melincoff, Nicaise, Riley; each received >13.5M votes.
- Ratification of Ernst & Young AG as independent auditor for FY 2026 approved with ~25.9M for, 1.1M against.
- Broker non-votes of ~11.7M shares on director elections.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1819411/000110465926077820/0001104659-26-077820-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1819411/000110465926077820/tm2618851d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-077820

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer